Efficacy, Safety, Tolerability of Pegaptanib Sodium (Macugen) in Filipino Patients With Neovascular Age Related Macular Degeneration.
This study has been withdrawn prior to enrollment.
Information provided by:
First received: January 8, 2009
Last updated: March 4, 2015
Last verified: March 2015
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
|Study Status:||This study has been withdrawn prior to enrollment.|
|Estimated Study Completion Date:||May 2009|
|Estimated Primary Completion Date:||May 2009 (Final data collection date for primary outcome measure)|